Filed in archive
News
by Rhys on April 30, 2006
Researchers are excited about a pill, designed to treat diabetes, that may be effective in halting the progress of Alzheimer's.
A clinical trial will soon begin, supplying thousands of Alzheimer's patients with the diabetes drug Avandia, to halt the progress of the disease.
A preliminary experiment involving 511 Alzheimer's patients found signals that Avandia might help...
Those results, combined with other evidence that the diabetes pathway is important, have Avandia maker GlaxoSmithKline poised to open three Phase III clinical trials this summer to test whether the diabetes drug, also called rosiglitazone, might protect certain patients' brains.
Diabetes has long been listed a risk factor for Alzheimer's later in life because it damages blood vessels that supply the brain.
You can read the rest of the article here, which also lists other risk factors for Alzheimer's, and early behaviors that may lead to the disease.
These are truly remarkable, hopeful times that we live in.
Tags:
alzheimers
diabetes
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/21253
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Could Diabetes Medication Help Alzheimer's Patients?:
|
Rating: 9.60 out of 5 vote(s) cast.
|
Response from:
Yasmin birth control
(05/29/07 4:16am)
Preliminary studies of Pioglitazone, an FDA-approved medication for type 2 diabetes indicate that it could reduce inflammatory reactions to the abnormal accumulations of amyloid beta protein that occur in Alzheimer’s disease.Other research suggests that blood sugar and insulin levels, which are regulated by pioglitazone, can also influence memory and thinking in people with Alzheimer’s.
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
